Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Sees Significant Increase in Short Interest

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) was the recipient of a large growth in short interest in the month of October. As of October 30th, there was short interest totaling 1,324 shares, a growth of 586.0% from the October 15th total of 193 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 8,514 shares, the short-interest ratio is currently 0.2 days.

Oaktree Acquisition Corp. III Life Sciences Stock Up 0.1%

NASDAQ:OACC opened at $10.71 on Wednesday. Oaktree Acquisition Corp. III Life Sciences has a twelve month low of $10.50 and a twelve month high of $10.93. The business has a 50 day moving average price of $10.74 and a two-hundred day moving average price of $10.70.

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) last posted its quarterly earnings data on Wednesday, August 12th. The company reported $0.07 earnings per share (EPS) for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded Oaktree Acquisition Corp. III Life Sciences from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, October 2nd. One analyst has rated the stock with a Hold rating. According to MarketBeat, the company has a consensus rating of “Hold”.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Periscope Capital Inc. bought a new position in Oaktree Acquisition Corp. III Life Sciences in the third quarter valued at $3,488,000. DLD Asset Management LP increased its stake in Oaktree Acquisition Corp. III Life Sciences by 0.9% in the 1st quarter. DLD Asset Management LP now owns 136,735 shares of the company’s stock valued at $1,447,000 after buying an additional 1,200 shares during the last quarter. Finally, Rangeley Capital LLC increased its stake in Oaktree Acquisition Corp. III Life Sciences by 52.8% in the 1st quarter. Rangeley Capital LLC now owns 61,188 shares of the company’s stock valued at $647,000 after buying an additional 21,156 shares during the last quarter.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a company in the life sciences sector. The company does not operate as a traditional life sciences manufacturer or service provider and does not currently market its own products. Its stated focus includes potential merger or acquisition opportunities involving pharmaceutical, biotechnology, medical device, diagnostics, and other healthcare-related businesses.